CM
HOOK

Crestline Management’s HOOKIPA Pharma HOOK Stock Holding History

Crestline Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,553
Closed -$91K – 238
2022
Q2 		$91K Sell
5,553
-72
-1% -$1.19K 0.01% 210
2022
Q1 		$128K Buy
+5,625
New +$101K 0.02% 234

Other funds holding HOOK

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Crestline Management's HOOK Position: Q3 2022 in Review

Crestline Management sold out of HOOKIPA Pharma (HOOK) in Q3 2022, closing a stake of 5,553 shares — an estimated $91K sold.

Crestline Management first reported a position in HOOK in Q1 2022 and held it in 2 quarters. The position peaked at $128K in Q1 2022. 54 funds tracked by Wall St. Rank hold HOOK as of Q3 2022.

  • Crestline Management reported no remaining HOOKIPA Pharma position as of Q3 2022 after selling out during the quarter.
  • Crestline Management sold 5,553 HOOKIPA Pharma shares in Q3 2022, an estimated $91K.
  • Crestline Management first reported a position in HOOKIPA Pharma in Q1 2022 and held it in 2 quarters.
  • Crestline Management's HOOKIPA Pharma position peaked at $128K in Q1 2022.
  • 54 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2022.

Based on Crestline Management's 13F filing for Q3 2022, filed 14 Nov 2022.